Mesenchymal stem cell transplantation in the treatment of type 1 diabetic patients
Not Applicable
- Conditions
- Type 1 diabetes.Insulin-dependent diabetes mellitus
- Registration Number
- IRCT138810271414N8
- Lead Sponsor
- Endocrinology & Metabolism Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
signing informed consent, presence of type 1 diabetes, age 5-30 years, duration of diabetes up to 20 weeks, being in stages before the onset of severe irreversible complications
Exclusion criteria: history of DKA presentation, having acute infectious diseases
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CD markers. Timepoint: 3 months. Method of measurement: serum analysis.;Anti insulin Ab. Timepoint: 3 months. Method of measurement: serum analysis.;Anti receptor Ab. Timepoint: 3 months. Method of measurement: serum analysis.;Anti GAD. Timepoint: 3 months. Method of measurement: serum analysis.;C-peptide. Timepoint: 3 months. Method of measurement: serum analysis.;HbA1c. Timepoint: 3 months. Method of measurement: blood sample analysis.;Insulin dose. Timepoint: 3 months. Method of measurement: mean dose of insulin injected in one week.;Mean of FBS. Timepoint: 3 months. Method of measurement: blood sample.;Mean of BS. Timepoint: 3 months. Method of measurement: blood sample.
- Secondary Outcome Measures
Name Time Method